This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Chlorpromazine-Induced Skin Pigmentation With Short-Term Use in a Patient With Bipolar Disorder: A Case Report

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Chlorpromazine is known, in rare instances, to induceskin pigmentation in areas exposed to sunlight.1 The prevalencein chronic, hospitalized patients is reported as 1.0% to 2.9%.2Some authors report chlorpromazine-induced skin pigmentationas irreversible,3 while some findings4 indicate that it is completelyreversible and that a variety of neuroleptics, includingother phenothiazines, are used to replace chlorpromazine withoutrisk of reemergence of pigmentation.4


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 9

Quick Links: Bipolar Disorder

References